HUTCHMED (China) (HMDCF) Cost of Revenue (2015 - 2021)
HUTCHMED (China) (HMDCF) reported Cost of Revenue of $12.3 million for Q2 2021, up 298.64% year-over-year from $3.1 million in Q2 2020, and up 114.09% quarter-over-quarter from $5.7 million in Q1 2021.
HUTCHMED (China) (HMDCF) Cost of Revenue (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has 6 years of Cost of Revenue data on file, last reported at $12.3 million in Q2 2021.
- Cost of Revenue for Q2 2021 came in at $12.3 million, up 298.64% year-over-year; the trailing twelve-month figure through Jun 2021 was $23.7 million (up 99.06% YoY), and the FY2025 annual result was $36.3 million, down 25.32% from the prior year.
- Cost of Revenue improved to $12.3 million in Q2 2021 per HMDCF's latest filing, from $5.7 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $12.3 million in Q2 2021 and troughed at $2.1 million in Q4 2019.
- A 4-year average of $4.6 million and a median of $4.1 million in 2018 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2019 and 2021: Cost of Revenue tumbled 49.4% in 2019, then soared 298.64% in 2021.
- A 4-year view of Cost of Revenue shows it stood at $4.1 million in 2018, then plunged by 49.4% to $2.1 million in 2019, then soared by 49.18% to $3.1 million in 2020, then soared by 298.64% to $12.3 million in 2021.
- Business Quant data shows HMDCF's Cost of Revenue at $12.3 million in Q2 2021, $5.7 million in Q1 2021, and $3.1 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 696.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 641.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 133.40 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 34.44 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 13.80 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 586.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 155.56 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 52.68 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 222.00 Mn |
| 10 | HUTCHMED (China) | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 12.27 Mn |
| Jun 30, 2021 | 12.27 Mn |
| Mar 31, 2021 | 5.73 Mn |
| Mar 31, 2021 | 5.73 Mn |
| Jun 30, 2020 | 3.08 Mn |
| Jun 30, 2020 | 3.08 Mn |
| Mar 31, 2020 | 2.59 Mn |
| Mar 31, 2020 | 2.59 Mn |
| Dec 31, 2019 | 2.06 Mn |
| Dec 31, 2019 | 2.06 Mn |
| Sep 30, 2019 | 4.16 Mn |
| Sep 30, 2019 | 4.16 Mn |
| Jun 30, 2019 | 3.72 Mn |
| Jun 30, 2019 | 3.72 Mn |
| Mar 31, 2019 | 3.79 Mn |
| Mar 31, 2019 | 3.79 Mn |
| Dec 31, 2018 | 4.08 Mn |
| Dec 31, 2018 | 4.08 Mn |
| Sep 30, 2018 | 4.27 Mn |
| Sep 30, 2018 | 4.27 Mn |